Alona Muzikansky

Alona Muzikansky

UNVERIFIED PROFILE

Are you Alona Muzikansky?   Register this Author

Register author
Alona Muzikansky

Alona Muzikansky

Publications by authors named "Alona Muzikansky"

Are you Alona Muzikansky?   Register this Author

100Publications

3371Reads

32Profile Views

Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.

Clin Lung Cancer 2019 Sep 11;20(5):339-349. Epub 2019 May 11.

Department of Radiology, Massachusetts General Hospital, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.05.006DOI Listing
September 2019

Early molecular oxidative stress biomarkers of ischemic penumbra in acute stroke.

Neurology 2019 Sep 27;93(13):e1288-e1298. Epub 2019 Aug 27.

From the J. Philip Kistler Stroke Research Center (S.L., N.S.R., L.M.B., A.C., R.E.G., T.K.T., B.T.), Department of Neurology, and Department of Radiology (H.L., G.J.H.), Massachusetts General Hospital and Harvard Medical School, Boston; Department of Neurology (M.K., K.L.F.), Rhode Island Hospital, Alpert Medical School of Brown University, Providence; Massachusetts General Hospital Biostatistics Center (A.M.), Boston; Neuroprotection Research Laboratory (K.A., A.T.S., L.-D.D.P., E.H.L.), Neuroscience Center, Departments of Neurology and Radiology, Massachusetts General Hospital and Harvard Medical School; Athinoula A. Martinos Center for Biomedical Imaging (O.W.), Massachusetts General Hospital and Harvard Medical School, Charlestown; Antioxidant Research Laboratory (J.B.B.), Jean Mayer USDA Human Nutrition Research Center on Aging, and Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy (P.E.M.), Tufts University; and Department of Neurology (S.K.F.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000008158DOI Listing
September 2019

Septal bowing and pulmonary artery diameter on computed tomography pulmonary angiography are associated with short-term outcomes in patients with acute pulmonary embolism.

Emerg Radiol 2019 Aug 2. Epub 2019 Aug 2.

Center for Vascular Emergencies, Department of Emergency Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10140-019-01709-9DOI Listing
August 2019

Multimodal quantitative imaging of brain cancer in cultured cells.

Biomed Opt Express 2019 Aug 29;10(8):4237-4248. Epub 2019 Jul 29.

Advanced Biophotonics Laboratory, UMASS Lowell, Lowell, MA 01851, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1364/BOE.10.004237DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701554PMC
August 2019

Angiotropism in primary cutaneous melanoma is associated with disease progression and distant metastases: A retrospective study of 179 cases.

J Cutan Pathol 2019 Jul 14;46(7):498-507. Epub 2019 Apr 14.

Pathology Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.13461DOI Listing
July 2019

Impact of Age on Outcomes with Immunotherapy in Patients with Non-Small Cell Lung Cancer.

J Thorac Oncol 2019 Mar 23;14(3):547-552. Epub 2018 Nov 23.

Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183345
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.11.011DOI Listing
March 2019

Opposing Roles of apolipoprotein E in aging and neurodegeneration.

Life Sci Alliance 2019 02 13;2(1). Epub 2019 Feb 13.

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26508/lsa.201900325DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374993PMC
February 2019

Fluorescence Polarization of Methylene Blue as a Quantitative Marker of Breast Cancer at the Cellular Level.

Sci Rep 2019 Jan 30;9(1):940. Epub 2019 Jan 30.

Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 40 Blossom Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-38265-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353996PMC
January 2019

Role of Patient Coping Strategies in Understanding the Effects of Early Palliative Care on Quality of Life and Mood.

J Clin Oncol 2018 01 15;36(1):53-60. Epub 2017 Nov 15.

Joseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.7221DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756320PMC
January 2018

Differential UBE2C and HOXA1 expression in melanocytic nevi and melanoma.

J Cutan Pathol 2017 Oct 21;44(10):843-850. Epub 2017 Jul 21.

Pathology Service and Dermatopathology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12997DOI Listing
October 2017

Lymphatic invasion predicts sentinel lymph node metastasis and adverse outcome in primary cutaneous melanoma.

J Cutan Pathol 2017 Sep 19;44(9):734-739. Epub 2017 Jun 19.

Pathology Service, Massachusetts General Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12969DOI Listing
September 2017

Bone marrow response as a potential biomarker of outcomes in glioblastoma patients.

J Neurosurg 2017 Jul 14;127(1):132-138. Epub 2016 Oct 14.

Harvard Medical School; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2016.7.JNS16609DOI Listing
July 2017

Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases.

J Thorac Oncol 2017 03 2;12(3):458-466. Epub 2016 Nov 2.

Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.10.015DOI Listing
March 2017

Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial.

J Clin Oncol 2017 Mar 28;35(8):834-841. Epub 2016 Dec 28.

Jennifer S. Temel, Joseph A. Greer, Areej El-Jawahri, William F. Pirl, Elyse R. Park, Vicki A. Jackson, Mihir Kamdar, Juliet Jacobsen, Eva H. Chittenden, Simone P. Rinaldi, Emily R. Gallagher, Justin R. Eusebio, Alona Muzikansky, and David P. Ryan, Massachusetts General Hospital; Jennifer S. Temel, Joseph A. Greer, Areej El-Jawahri, William F. Pirl, Elyse R. Park, Vicki A. Jackson, Mihir Kamdar, Juliet Jacobsen, Eva H. Chittenden, Alona Muzikansky, and David P. Ryan, Harvard Medical School, Boston, MA; Anthony L. Back, University of Washington, Seattle, WA; and Zhigang Li, Geisel School of Medicine at Dartmouth, Lebanon, NH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.5046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455686PMC
March 2017

Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.

J Neurooncol 2017 02 16;131(3):603-610. Epub 2016 Nov 16.

Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center, Yawkey 9E, 55 Fruit Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2332-5DOI Listing
February 2017

End-of-Life Care in Patients with Metastatic Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations.

J Palliat Med 2016 12 14;19(12):1316-1319. Epub 2016 Sep 14.

2 Massachusetts General Hospital Cancer Center , Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jpm.2016.0180DOI Listing
December 2016

Acquired Resistance to First-Line Afatinib and the Challenges of Prearranged Progression Biopsies.

J Thorac Oncol 2016 11 20;11(11):2022-2026. Epub 2016 Aug 20.

Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864163084
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2016.06.032DOI Listing
November 2016

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.

Neuro Oncol 2016 06 21;18(6):849-54. Epub 2016 Feb 21.

Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (E.Q.L., D.A.R., A.D.N., L.N., M.L.R., B.M.A., N.D.A., L.D., J.S., D.L., S.F.R., J.P., K.H.S., S.C.G., S.H., P.Y.W.); Harvard Medical School, Boston, Massachusetts (E.Q.L., E.T.W., D.A.R., A.D.N., L.N., M.L.R., B.M.A., N.D.A., P.Y.W.); Massachusetts General Hospital, Boston, Massachusetts (A.M.); University of Pittsburgh, Pittsburgh, Pennsylvania (J.D.); University of California San Diego, La Jolla, California (S.K.); Beth Israel Deaconess Medical Center, Boston, Massachusetts (E.T.W.); Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire (C.E.F.); Geisel School of Medicine at Dartmouth, Hanover, New Hampshire (C.E.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864265PMC
June 2016

Health-related Quality of Life of Individuals With Neurofibromatosis Type 2: Results From the NF2 Natural History Study.

Otol Neurotol 2016 06;37(5):574-9

*Department of Neurology and Cancer Center, Massachusetts General Hospital, Boston, Massachusetts †Department of Neurology, Johns Hopkins Hospital, Baltimore, Maryland ‡Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts §Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts ||Department of Neurotology, House Clinic, Los Angeles, California.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00129492-201606000-000
Publisher Site
http://dx.doi.org/10.1097/MAO.0000000000001019DOI Listing
June 2016

Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.

J Neuropathol Exp Neurol 2016 06 22;75(6):516-26. Epub 2016 Apr 22.

From the Department of Neurology of the University of Iowa Hospitals & Clinics, Iowa City, Iowa (AS-P); Department of Biostatistics and Epidemiology of the University of Massachusetts, Amherst, Massachusetts (JQ); Massachusetts General Hospital Biostatistics Center, Boston, Massachusetts (AM); Department of Biostatistics, University of Washington, Seattle, Washington (SEM); Department of Pathology, School of Medicine of the University of Washington, Seattle, Washington (TJM); C. S. Kubik Laboratory for Neuropathology of the Massachusetts General Hospital (MPF), Department of Neurology of the Massachusetts General Hospital, Boston, Massachusetts (BTH); Department of Biostatistics of the Harvard T. H. Chan School of Public Health, Boston, Massachusetts (RAB); and Massachusetts Alzheimer Disease Research Center, Charlestown, Massachusetts (MPF, RAB, BTH).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnen/nlw026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250207PMC
June 2016

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.

J Clin Oncol 2016 05 14;34(14):1669-75. Epub 2016 Mar 14.

Jaishri O. Blakeley, Xiaobu Ye, Amanda L. Bergner, Laura M. Fayad, Shivani Ahlawat, and Michael A. Jacobs, Johns Hopkins University, Baltimore; Christopher Zalewski, National Institute on Deafness and Other Communication Disorders; Eva Dombi and Brigitte C. Widemann, National Cancer Institute, Bethesda, MD; Dan G. Duda, Alona Muzikansky, Vanessa L. Merker, Elizabeth R. Gerstner, Rakesh K. Jain, and Scott R. Plotkin, Massachusetts General Hospital; and Chris F. Halpin, Massachusetts Eye and Ear Infirmary, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.3817DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872317PMC
May 2016

Predictors Of Treatment Failure After Radiofrequency Ablation For Intramucosal Adenocarcinoma in Barrett Esophagus: A Multi-institutional Retrospective Cohort Study.

Am J Surg Pathol 2016 Apr;40(4):554-62

*Department of Pathology ¶Harvard Medical School, Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, MA †Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH ∥Columbia University Medical Center, Division of Digestive & Liver Diseases, New York, NY ‡Department of Pathology §Biostatistics Center, Harvard Medical School, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000566DOI Listing
April 2016

Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta.

BMC Biol 2016 Mar 31;14:25. Epub 2016 Mar 31.

MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12915-016-0248-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818459PMC
March 2016

Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma.

Oncologist 2016 Feb 1;21(2):214-9. Epub 2016 Feb 1.

Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA Division of Hematology/Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746092PMC
February 2016

Increased NY-ESO-1 expression and reduced infiltrating CD3+ T cells in cutaneous melanoma.

J Immunol Res 2015 14;2015:761378. Epub 2015 Apr 14.

Dermatopathology Unit, Pathology Service, Massachusetts General Hospital, Harvard Medical School, Warren Building 825, 55 Fruit Street, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/761378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411457PMC
January 2016

Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer.

J Thorac Oncol 2015 Dec;10(12):1670-4

*Department of Medicine, Massachusetts General Hospital, Boston, MA; †Department of Pathology, Massachusetts General Hospital, Boston, MA; ‡Memorial Sloan Kettering Cancer Center, New York, NY; ‖Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; §Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN; ¶Department of Medicine, Georgetown University Medical Center, Washington, DC; #University of California Irving Health, Orange, CA; **Dana-Farber Cancer Institute, Boston, MA; ††Beth Israel Deaconess Medical Center, Boston, MA; and ‡‡Ignyta, Inc., San Diego, CA.

View Article

Download full-text PDF

Source
http://ignyta.com/wp-content/uploads/2016/01/Durable-Clinica
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S155608641535087
Publisher Site
http://dx.doi.org/10.1097/01.JTO.0000473485.38553.f0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643748PMC
December 2015

Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors.

J Clin Oncol 2015 Oct 17;33(28):3186-92. Epub 2015 Aug 17.

Mrinal M. Gounder, Armando J. Sanchez, and Lisa M. DeAngelis, Memorial Sloan-Kettering Cancer Center and Weil Cornell Medical School, New York, NY; Lakshmi Nayak and Patrick Y. Wen, Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School; Alona Muzikansky, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Solmaz Sahebjam, Moffitt Cancer Center, University of South Florida, Tampa, FL; Serena Desideri, Xiaobu Ye, and Stuart Grossman, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore; S. Percy Ivy, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD; L. Burt Nabors, University of Alabama at Birmingham, Birmingham, AL; and Michael Prados, University of California at San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.1525DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857195PMC
October 2015

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.

Neuro Oncol 2015 Jun 7;17(6):862-7. Epub 2015 Jan 7.

Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (E.Q.L., D.A.R., A.D.N., L.N., R.B., M.L.R., K.H., C.M., K.H.S., S.C.G., B.W., K.L.L., P.Y.W.); University of Virginia, Charlottesville, Virginia (D.S.); University of Pittsburgh, Pittsburgh, Pennsylvania (J.D.); Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (A.S.C., T,T.B., A.M.); Central DuPage Hospital, Warrenville, Illinois (S.A.G.); Northwestern University, Chicago, Illinois (J.J.R.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/17/6/862.fu
Web Search
http://neuro-oncology.oxfordjournals.org/cgi/doi/10.1093/neu
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou350DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483124PMC
June 2015

Clinical significance of microscopic melanoma metastases in the nonhottest sentinel lymph nodes.

JAMA Surg 2015 May;150(5):465-72

Pathology Service and Dermatopathology Unit, Massachusetts General Hospital, Harvard Medical School, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamasurg.2014.3843DOI Listing
May 2015

Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.

J Natl Cancer Inst 2015 Apr 20;107(4). Epub 2015 Feb 20.

Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston MA (EIA, SVK, NDK, GS, DPK, VA, YH, SG, MS, YB, DF, RKJ); Department of Surgery (Austin Health), University of Melbourne, Studley Road Heidelberg, VIC, Australia (EIA); Novogen, Hornsby, NSW, Australia (EIA); Novartis Institutes for BioMedical Research, Cambridge, MA (NDK); Centenary Institute of Cancer Medicine and Cell Biology, University of Sydney, Camperdown, NSW, Australia (SG); Department of Biostatistics, Massachusetts General Hospital Biostatistics Center, Boston, Massachusetts (AM, DMF); Department of Pathology, NYU Langone Medical Center and Medical School, New York, NY (MS); Dyax Corp., Burlington, MA (DTD, LD); Departments of Medical Oncology and Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (SG); Tokai Pharmaceuticals, Inc., Cambridge, MA (DTD); Merck Serono S. A., Geneva, Switzerland (LD).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402365PMC
April 2015

Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.

Fertil Steril 2015 Mar 31;103(3):761-8.e1. Epub 2014 Dec 31.

Department of Neurology and Cancer Center, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fertnstert.2014.11.021DOI Listing
March 2015

Examining perceived cancer risk among patients with neurofibromatosis type 1.

J Neurooncol 2015 Mar 6;122(1):127-33. Epub 2015 Jan 6.

Department of Psychiatry, Mongan Institute for Health Policy, Benson-Henry Institute for Mind-Body Medicine, Cancer Center, Massachusetts General Hospital/Harvard Medical School, 50 Staniford St, 907, Boston, MA, 02114, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1689-6DOI Listing
March 2015

Outcome of patients with de novo versus nevus-associated melanoma.

J Am Acad Dermatol 2015 Jan 18;72(1):54-8. Epub 2014 Oct 18.

Pathology Service and Dermatopathology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.09.028DOI Listing
January 2015

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.

Neurology 2015 Jan 19;84(3):280-6. Epub 2014 Dec 19.

From the Division of Cancer Neurology, Department of Neurology (A.D.N., E.Q.L., P.Y.W.), and Departments of Pathology (K.L.L.) and Medicine (R.B.), Brigham and Women's Hospital, Boston, MA; Center for Neuro-Oncology (A.D.N., S.N.H., D.A.R., R.B., E.Q.L., L.D., D.L., M.G., K.H.S., C.M., P.Y.W.), Dana-Farber/Brigham and Women's Cancer Center; Department of Medicine (R.B.), Harvard Medical School (A.D.N., K.L.L., D.A.R., T.T.B., S.R.P., E.T.W., R.B., E.Q.L., P.Y.W.), Boston; Department of Medical Oncology, Center for Molecular Oncologic Pathology (K.L.L., S.H.), and Departments of Medical Oncology and Cancer Biology (R.B.), Dana-Farber Cancer Institute, Boston; Massachusetts General Hospital Biostatistics Center (A.M.); Brain Tumor Center (T.J.K.), Memorial Sloan-Kettering Cancer Center, New York, NY; Pappas Center for Neuro-Oncology (T.T.B., S.R.P.), Massachusetts General Hospital, Boston; Department of Neurology (J.J.R.), Northwestern University Feinberg School of Medicine, Chicago, IL; Brain Tumor Center (E.T.W.), Beth-Israel Deaconess Medical Center, Boston; Adult Neuro-Oncology Program (J.D.), University of Pittsburgh Medical Center, Pittsburgh, PA; Comprehensive Cancer Center (G.J.L.), Wake Forest University Baptist Medical Center, Winston-Salem, NC; and Departments of Neurosurgery and Neurology (S.P.), Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000001153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335993PMC
January 2015

Perceptions of health status and survival in patients with metastatic lung cancer.

J Pain Symptom Manage 2014 Oct 27;48(4):548-57. Epub 2014 Mar 27.

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2013.10.016DOI Listing
October 2014

Outcomes and patterns of care in adult skull base chondrosarcomas from the SEER database.

J Clin Neurosci 2014 Sep 30;21(9):1497-502. Epub 2014 Apr 30.

Department of Neurosurgery, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, 55 Fruit Street, Yawkey 9E-9026, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2014.02.005DOI Listing
September 2014

Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.

J Clin Neurosci 2014 Sep 19;21(9):1490-6. Epub 2014 May 19.

Department of Neurosurgery, Stephen L. Harris Center for Chordoma Care, Massachusetts General Hospital, 55 Fruit Street, Yawkey 9E-9026, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2014.02.008DOI Listing
September 2014

The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.

J Thorac Oncol 2014 Sep;9(9):1363-9

*Division of Hematology/Oncology, Department of Medicine; †Division of Thoracic Surgery; ‡Biostatistics Center; §Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston,Massachusetts; and ‖Department of Thoracic Surgery, Guangdong General Hospital, Southern Medical University, Guangdong, China.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153068
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000266DOI Listing
September 2014

Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.

Am J Med Genet A 2014 Jun 24;164A(6):1431-7. Epub 2014 Mar 24.

Department of Neurology and Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.36466DOI Listing
June 2014

Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients.

Cancer Chemother Pharmacol 2014 Jun 8;73(6):1197-204. Epub 2014 Apr 8.

Center for Neurofibromatosis and Allied Disorders, Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2456-2DOI Listing
June 2014

Tau pathology does not affect experience-driven single-neuron and network-wide Arc/Arg3.1 responses.

Acta Neuropathol Commun 2014 Jun 10;2:63. Epub 2014 Jun 10.

Alzheimer's Disease Research Laboratory, Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown 02129, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2051-5960-2-63DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229905PMC
June 2014

Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion.

Clin Nucl Med 2014 May;39(5):e301-7

From the *Department of Radiology, †Department of Neurology and Cancer Center, ‡Biostatistics Center, Massachusetts General Hospital, Boston, MA; and §Corades, S.L., Madrid, Spain.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00003072-201405000-000
Publisher Site
http://dx.doi.org/10.1097/RLU.0b013e3182a757d3DOI Listing
May 2014

Postoperative intensive care unit requirements after elective craniotomy.

World Neurosurg 2014 Jan 24;81(1):165-72. Epub 2012 Nov 24.

Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18788750120136
Publisher Site
http://dx.doi.org/10.1016/j.wneu.2012.11.068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596491PMC
January 2014

Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients.

Otol Neurotol 2014 Jan;35(1):e50-6

*Department of Neurology and Cancer Center, †Biostatistics Center, and ‡Neurosurgical Service, Massachusetts General Hospital, Boston, Massachusetts; and §Neurotology, House Clinic, Los Angeles, California, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAO.0000000000000239DOI Listing
January 2014

Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma.

J Neurooncol 2013 Oct 5;115(1):71-7. Epub 2013 Jul 5.

Department of Neuro-Oncology, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-013-1196-1DOI Listing
October 2013

The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.

Ann Thorac Surg 2013 Sep 8;96(3):962-8. Epub 2013 Aug 8.

Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2013.05.091DOI Listing
September 2013

Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia.

Mod Pathol 2013 Jun 11;26(6):751-61. Epub 2013 Jan 11.

Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2012.218DOI Listing
June 2013

Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease.

J Neuropathol Exp Neurol 2013 Jun;72(6):462-71

Mass General Institute for Neurodegenerative Disease, Massachusetts General Hospital, Massachusetts Alzheimer Disease Research Center, and Harvard Medical School, Charlestown, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NEN.0b013e3182933788DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661683PMC
June 2013

Electronic prompt to improve outpatient code status documentation for patients with advanced lung cancer.

J Clin Oncol 2013 Feb 2;31(6):710-5. Epub 2013 Jan 2.

Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.2203DOI Listing
February 2013

Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.

Genet Med 2012 Dec 9;14(12):977-82. Epub 2012 Aug 9.

Department of Neurology and Cancer Center, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2012.85DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982605PMC
December 2012

The distribution of microscopic melanoma metastases in sentinel lymph nodes: implications for pathology protocols.

Am J Surg Pathol 2012 Dec;36(12):1841-8

Pathology Service and Dermatopathology Unit, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31826d25f9DOI Listing
December 2012

An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma.

Hum Pathol 2012 Aug 26;43(8):1265-72. Epub 2012 Jan 26.

Department of Dermatology, Dermatopathology Section, Boston University School of Medicine, Boston, MA 02118, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2011.10.005DOI Listing
August 2012

A new BATTLE in the evolving war on cancer.

Cancer Discov 2011 Jun 1;1(1):14-6. Epub 2011 Jun 1.

Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/content/early/2011/0
Web Search
http://cancerdiscovery.aacrjournals.org/cgi/doi/10.1158/2159
Publisher Site
http://dx.doi.org/10.1158/2159-8274.CD-11-0044DOI Listing
June 2011